Previous page Next page

iEmoji Feeds @ESMO - Eur. Oncology (myESMO) 3

23.

myESMO
#ESMOSarcoma22: Available to all delegates on the platform - key publications on
ESMO Essentials for Clinician… twitter.com/i/web/status/1…
29 Jan 22 copy & paste +upvote -downvote #ESMOSarcoma22: Available to all delegates on the platform - key publications on 👇 ➡️ ESMO Essentials for Clinician… https://t.co/IvOOYx0qD3

24.

myESMO
Abstract submission is open until 17 Jan 2022 Take your chance to present your #research at #ELCC22, the onsite +… twitter.com/i/web/status/1…
07 Jan 22 copy & paste +upvote -downvote Abstract submission is open until 17 Jan 2022 ⏳ Take your chance to present your #research at #ELCC22, the onsite +… https://t.co/yhfSWqPHaF
25.
myESMO
#ELCC22 is calling for abstracts: make sure yours are in by 17 January Shape the future of #cancerresearch &… twitter.com/i/web/status/1…
15 Dec 21 copy & paste +upvote -downvote #ELCC22 is calling for abstracts: make sure yours are in by 17 January 👉 Shape the future of #cancerresearch &… https://t.co/KuowzrXenw
26.
myESMO
ESMO E-Learning: Oncological Considerations for the #LGBTQ Patient
#cancercare in LGBTQ patients
strategies f… twitter.com/i/web/status/1…
14 Dec 21 copy & paste +upvote -downvote ESMO E-Learning: Oncological Considerations for the #LGBTQ Patient ➡️ #cancercare in LGBTQ patients ➡️ strategies f… https://t.co/h141HMvM87
27.
myESMO
#ESMOImmuno21: Can #ctDNA changes after neoadjuvant therapy inform management of early #NSCLC?
twitter.com/i/web/status/1…
09 Dec 21 copy & paste +upvote -downvote #ESMOImmuno21: Can #ctDNA changes after neoadjuvant therapy inform management of early #NSCLC? 👉… https://t.co/sEeuZFf5mq
28.
myESMO
#GastricCancer webinar starts in a few hoursRegister for free to join this live discussion on the current paradigm… twitter.com/i/web/status/1…
23 Nov 21 copy & paste +upvote -downvote #GastricCancer webinar starts in a few hours📌Register for free to join this live discussion on the current paradigm… https://t.co/8IsSfvmIZ9
29.
myESMO
Diversity: having a seat at the table
Inclusion: having a voice
Belonging: having that voice be heard

We belo… twitter.com/i/web/status/1…
Retweet of status by @clacardone
04 Nov 21 copy & paste +upvote -downvote 📣Diversity: having a seat at the table 📣Inclusion: having a voice 📣Belonging: having that voice be heard We belo… https://t.co/GPV6nzHTep
30.
myESMO
FDG-PET can help guide discontinuation of ICI therapy in pts with #melanoma
complete metabolic response after 12-… twitter.com/i/web/status/1…
Retweet of status by @pawel_sobczuk
03 Nov 21 copy & paste +upvote -downvote FDG-PET can help guide discontinuation of ICI therapy in pts with #melanoma 🌟complete metabolic response after 12-… https://t.co/UEG2c4NART
31.
myESMO
2 Nov, at 18:30 CET (13:30 EDT): Take this opportunity to interact with the experts developing the ESMO Guideline… twitter.com/i/web/status/1…
26 Oct 21 copy & paste +upvote -downvote 📌 2 Nov, at 18:30 CET (13:30 EDT): Take this opportunity to interact with the experts developing the ESMO Guideline… https://t.co/PLFDrHCL2l
32.
myESMO
First sessions at #MAP2021 Still time to register (free) to learn more on #translationalresearch fundamentals, &… twitter.com/i/web/status/1…
Retweet of status by @myESMO
08 Oct 21 copy & paste +upvote -downvote First sessions at #MAP2021 🙌 Still time to register (free) to learn more on #translationalresearch fundamentals, &… https://t.co/L6lSmKQrSB
33.
myESMO
There is still time to register (for free ) for the 2021 @myESMO #MAP2021 congress, which will start tomorrow (Oct… twitter.com/i/web/status/1…
Retweet of status by @BenWestphalen
05 Oct 21 copy & paste +upvote -downvote There is still time to register (for free 🤩) for the 2021 @myESMO #MAP2021 congress, which will start tomorrow (Oct… https://t.co/iKBMDFa8Lm

...but wait! There's more!

23.

fakhright
fakhright @fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
14 Jan 13 copy & paste +upvote -downvote astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat* 🙈🙈🙊
Previous page Next page
https://www.iemoji.com/feed/myESMO
Back to top